Apomorphine Hydrocloride Injection
Product Images NDC 52817-720

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Apomorphine Hydrocloride (NDC 52817-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Chemical structure of apomorphine hydrochloride hemihydrate, showing three fused rings with hydroxyl groups and a methylated nitrogen atom, along with its associated hydrochloride and water of hydration components.*

FDA Label Image

Figure 2 (Image 02)

A line graph titled "UPDRS Motor Scores" depicting change from predose over time in minutes. Two lines compare Pooled APOKYN (solid line with diamond markers) showing a sharp decrease then gradual return, and Placebo (dashed line) showing a smaller initial decrease and leveling off before returning towards baseline by 90 minutes.*

FDA Label Image

Apomorphine Hydrocloride Pen (Image 03)

The image shows an APOKYN PEN, a subcutaneous injection device for apomorphine hydrochloride. The pen is cylindrical and gray with green accents, including a green band and a green cap. The brand name APOKYN PEN is printed prominently on the body. The pen features a dose indicator window near the cap. The labeler TruPharma, LLC, is associated with this product.*

FDA Label Image

Gray Pen Cap (Image 04)

Apomorphine hydrochloride 30 mg/3 mL injection label showing a single-dose vial with the proprietary name on the vial. The label includes a scale marking and a volume indicator, indicating the vial holds 3 mL of the solution. The labeler TruPharma, LLC is not visible in the image.*

FDA Label Image

Gray Pen Body (Image 05)

An illustration of a syringe injection device labeled with parts marked as b, c, d, and e, showing components related to apomorphine hydrochloride injection for subcutaneous administration.*

FDA Label Image

Pen Needle Unit (Image 06)

An instructional illustration depicting four components related to the apomorphine hydrochloride injection: a syringe needle (f), a plunger or stopper part (g), a needle cap labeled (h), and a finger pad or applicator (i). The drawing is line art and appears to show parts for subcutaneous injection preparation or administration.*

FDA Label Image

Cartridge (Image 07)

An illustration of a syringe or injection device labeled with three pointers (i, j, k) indicating specific parts or components of the device. No text or numeric details are present on the image.*

FDA Label Image

Teal Cartridge Holder (Image 08)

apomorphine hydrochloride 30 mg/3 mL injection vial image. The black and white line drawing shows a single-dose vial or cartridge with distinct features including a needle end and a filled chamber for subcutaneous injection. No other text or branding is visible in the image.*

FDA Label Image

Image (Image 09)

An instructional diagram illustrating an incorrect method of handling a syringe with a needle before injection, indicated by a large X mark crossing out the image. The image shows hands holding a syringe and needle, with a line striking through the entire scene, implying this action should be avoided.*

FDA Label Image

Needle (Image 10)

Illustration showing a comparison between a new needle and a reused needle for subcutaneous injection. The new needle appears straight and intact, while the reused needle is bent, highlighting differences in needle condition after use.*

FDA Label Image

Step 1 (Image 11)

An instructional illustration showing a step to remove the cap from a prefilled subcutaneous injection pen, preparing the device for administration of apomorphine hydrochloride injection.*

FDA Label Image

Step 2 (Image 12)

An instructional illustration showing a hand attaching a needle or device to a syringe filled with apomorphine hydrochloride injection. The image demonstrates the motion of connecting the syringe components, emphasizing safe preparation before subcutaneous administration.*

FDA Label Image

Step 3 (Image 13)

An instructional illustration showing a hand inserting a syringe needle into the stopper of a vial labeled for injection. The green border with number 3 indicates a step in the injection preparation process.*

FDA Label Image

Step 4 (Image 14)

An instructional diagram numbered 4, showing hands manipulating a subcutaneous injection pen or syringe. The arrows indicate twisting or turning actions on parts of the device, suggesting steps for preparing or using the injection.*

FDA Label Image

Step 5 (Image 15)

An instructional diagram showing a subcutaneous injection syringe for apomorphine hydrochloride 30 mg/3 mL by TruPharma, LLC. The image highlights a red line mark indicating a 0.6 mL measurement on the syringe barrel.*

FDA Label Image

Step 6 (Image 16)

An instructional illustration showing a close-up of hands preparing a subcutaneous injection of apomorphine hydrochloride. The image depicts twisting or removing the cap from a vial or syringe, indicated by an arrow. The panel is labeled with the number 6, suggesting it is part of a multi-step guide.*

FDA Label Image

Step 7 (Image 17)

Illustration showing a step in the preparation of apomorphine hydrochloride injection. It depicts a hand twisting the cap off a vial or syringe, indicated by curved arrows suggesting a turning motion. The image is part of an instructional guide for the subcutaneous injection dosage form.*

FDA Label Image

Step 8 (Image 18)

An instructional diagram showing a close-up of hands adjusting a dial or cap on a syringe or injection pen, labeled with a step number 8 in the top left corner, indicating a step in the preparation or administration process for a subcutaneous injection device.*

FDA Label Image

Step 9 (Image 19)

An instructional illustration showing a hand holding a syringe with attached needle upright, presumably preparing for a subcutaneous injection. The syringe is held between the thumb and forefinger, with the plunger visible at the bottom.*

FDA Label Image

Step 10 (Image 20)

Instructional diagram illustrating the process of preparing a device for apomorphine hydrochloride subcutaneous injection. The first panel shows a hand rotating a cap or component on the injection device. The second panel provides a close-up view of the device's internal mechanism with visible connectors or puncture elements.*

FDA Label Image

Step 11 (Image 21)

An instructional illustration showing a close-up of hands holding and preparing a syringe for injection. The syringe is being secured or adjusted, indicating a step in the administration process for a subcutaneous injection.*

FDA Label Image

Step 12 (Image 22)

An instructional diagram depicting a hand holding a syringe with the needle pointed downward, positioned above another hand. The illustration likely demonstrates proper technique for preparing or administering a subcutaneous injection, relevant for apomorphine hydrochloride injection.*

FDA Label Image

Step 13 (Image 23)

An instructional illustration showing a hand holding a small injection vial with the thumb pressing down on the vial cap, demonstrating how to open or activate the apomorphine hydrochloride 30 mg/3 mL subcutaneous injection vial from TruPharma, LLC.*

FDA Label Image

Step 14 (Image 24)

An instructional illustration showing a hand holding a syringe with a needle cap being removed or attached, positioned above a small vial or container within a plastic tray. The image is labeled with the number 14 in the upper left corner, indicating a step in a multi-step process likely related to preparing or using apomorphine hydrochloride injection.*

FDA Label Image

Step 15 (Image 25)

An instructional illustration showing how to prepare a subcutaneous injection. The image depicts a hand holding a syringe and aligning it with a vial or ampule cap, indicating a twisting or turning motion to open or attach the cap. The upper left corner displays the number 15 inside a green box, possibly indicating a step in the preparation process for apomorphine hydrochloride injection.*

FDA Label Image

Principal Display Panel (30 mg/3 mL Cartridge Carton)

Packaging label for Apomorphine Hydrochloride Injection, 30 mg/3 mL (10 mg/mL) in a 5 x 3 mL cartridge carton. The label indicates subcutaneous administration with use restricted to the APOKYN Pen and is Rx only. Distributed by TruPharma, LLC and manufactured by Berkshire Sterile Manufacturing, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.